2025-08-20 - Analysis Report
Okay, here's a comprehensive analysis of Hims & Hers Health Inc. (HIMS), incorporating all the provided information.

**Report: Hims & Hers Health Inc. (HIMS) Analysis**

**Company Overview:** Hims & Hers Health Inc. is a telehealth company offering personalized health and wellness solutions.

**1. Performance Relative to S&P 500 (VOO)**

*   **Cumulative Return (HIMS):** 169.91%
*   **Cumulative Return (VOO):** 69.44%
*   **Relative Divergence:**
    *   **Current:** 103.7
    *   **Range:** (Min: -89.9, Max: 286.3)
    *   **Relative Position within Range:** 51.5

**Analysis:** HIMS has significantly outperformed the S&P 500 (VOO) in terms of cumulative return. The relative divergence of 103.7 indicates substantial outperformance at the last data point. However, the relative position within the range (51.5) suggests that the current outperformance is around the median relative to its historical range. This suggests the possibility of normalization to closer performance with VOO.

**Alpha/Beta Analysis (HIMS vs. S&P 500)**

| Year       | CAGR     | MDD      | Alpha    | Beta   | Cap(B) |
|------------|----------|----------|----------|--------|--------|
| 2019-2021  | -46.0%   | 51.0%    | -84.0%   | -0.0   | 1.4    |
| 2020-2022  | -15.0%   | 72.1%    | -17.0%   | -0.0   | 1.4    |
| 2021-2023  | -51.0%   | 72.1%    | -69.0%   | -0.1   | 1.9    |
| 2022-2024  | 127.0%   | 78.4%    | 101.0%   | -0.1   | 5.1    |
| 2023-2025  | 165.0%   | 79.5%    | 112.0%   | -0.1   | 9.5    |

**Analysis:**

*   **CAGR:**  Shows a highly variable Compound Annual Growth Rate, from negative returns in earlier periods to substantial positive returns recently.
*   **MDD:** Maximum Drawdown indicates significant volatility with substantial drops in value.
*   **Alpha:** Historically negative Alpha values indicate underperformance relative to the risk-free rate, but recent years show significant positive Alpha, implying better-than-expected returns given the risk.
*   **Beta:**  The negative Beta values are unusual and suggest an inverse relationship with the S&P 500, which is unlikely. These Beta values should be investigated for accuracy.

**2. Recent Price Action**

*   **Current Price:** $45.10
*   **Last Market Data:**
    *   **Price:** $42.18
    *   **Previous Close:** $45.10
    *   **Change:** -6.47% (Significant drop)
*   **Moving Averages:**
    *   **5-day MA:** 46.91
    *   **20-day MA:** 54.69
    *   **60-day MA:** 53.05

**Analysis:** The recent price decline of -6.47% and the current price being below all three moving averages (5-day, 20-day, and 60-day) suggests a short-term downtrend. The substantial drop relative to the previous close warrants caution.

**3. Technical Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.329 (Low Risk)
*   **RSI:** 25.62 (Oversold)
*   **PPO:** -2.90
*   **Hybrid Signal:** cash_70%_Sell 0.1% of holdings (1 shares - Caution - MRI:0.33) (Cash Ratio: 70% on 2025-08-07)
*   **Recent (20-day) Relative Divergence Change:** -2.1 (Negative)
*   **Expected Return:** -18.0% (Long-Term, vs. S&P 500)

**Analysis:**

*   **MRI:** Indicates low market risk.
*   **RSI:**  The RSI value of 25.62 suggests that the stock is currently oversold, potentially indicating a possible bounce.
*   **PPO:** Negative PPO indicates a downward trend.
*   **Hybrid Signal:** Hybrid Signal suggests reducing holdings and increasing cash position. The message shows Caution.
*   **Relative Divergence Change:** The negative change in relative divergence suggests weakening relative performance.
*   **Expected Return:** The negative expected return indicates that, based on the analysis, the stock is expected to underperform the S&P 500 over the long term.

**4. Recent News & Significant Events**

*   **2025-08-17:** Major business developments, regulatory changes, or market events impacting HIMS.
*   **2025-08-20:** Analyst discussions on HIMS's recent performance and outlook.
*   **2025-08-18:** Notable stock volatility influenced by recent news, earnings, or executive actions.
*   **2025-08-19:** Market experts highlight both risks and opportunities.

**Analysis:** The recent news indicates potential volatility and significant events impacting HIMS. Investors should closely monitor news and company announcements to stay informed.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출        |
|------------|-------|-------------|
| 2025-08-04 | 0.19  | 0.54 B$     |
| 2025-05-05 | 0.22  | 0.59 B$     |
| 2024-11-04 | 0.35  | 0.40 B$     |
| 2024-08-05 | 0.06  | 0.32 B$     |
| 2025-08-04 | 0.06  | 0.32 B$     |

**Analysis:** EPS and Revenue show some volatility. The EPS increased from 0.06 to 0.35 and has decreased again. Also Revenue shows increase and decrease during the period.

**6. Financial Information**

**Revenue and Profitability**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-06-30 | $0.54B  | 76.39%        |
| 2025-03-31 | $0.59B  | 73.50%        |
| 2024-12-31 | $0.48B  | 76.81%        |
| 2024-09-30 | $0.40B  | 79.16%        |
| 2024-06-30 | $0.32B  | 81.30%        |

**Capital and Profitability**

| Quarter    | Equity | ROE     |
|------------|--------|---------|
| 2025-06-30 | $0.56B | 7.55%   |
| 2025-03-31 | $0.55B | 9.01%   |
| 2024-12-31 | $0.48B | 5.46%   |
| 2024-09-30 | $0.44B | 17.18%  |
| 2024-06-30 | $0.36B | 3.67%   |

**Analysis:**

*   **Revenue:** Revenue shows a positive trend overall, growing from $0.32B to $0.59B, then slightly decreasing to $0.54B.
*   **Profit Margin:** Profit margins are high, ranging from 73.50% to 81.30%, indicating strong operational efficiency.
*   **Equity:** Equity has been steadily increasing.
*   **ROE:** ROE has fluctuated significantly, with a high of 17.18% and a low of 3.67%.

**7. 종합적인 분석 (Overall Analysis)**

Hims & Hers Health Inc. (HIMS) has demonstrated significant outperformance relative to the S&P 500 (VOO) in terms of cumulative return. Recent news suggests potential volatility and impactful events. The recent price action indicates a short-term downtrend, and the technical indicators signal an oversold condition. The expected return is negative, but the MRI indicates low market risk.

The revenue and profitability show a generally positive trend, with high-profit margins. However, the ROE is unstable.

**Recommendation:** Given the recent downturn, negative expected return, and Hybrid signal, a cautious approach is warranted. Monitoring the news, earnings, and company announcements is crucial. An oversold RSI would indicate a possible buy signal to buy. The negative Beta should be investigated for accuracy.
